CVE-2013-3831
Unspecified vulnerability in the Oracle Portal component in Oracle Fusion Middleware 11.1.1.6.0...
Unspecified vulnerability in the Oracle Portal component in Oracle Fusion Middleware 11.1.1.6.0 allows remote authenticated users to affect confidentiality and integrity via unknown vectors related to Demos.
Exploit likelihood
What each source reports
NVD Score used
Unspecified vulnerability in the Oracle Portal component in Oracle Fusion Middleware 11.1.1.6.0 allows remote authenticated users to affect confidentiality and integrity via unknown vectors related to Demos.
- Record
CVE-2013-3831- CVSS 2.0
- 5.5 Medium
AV:N/AC:L/Au:S/C:P/I:P/A:N - Updated
- 2026-11-02
CVE List No score
Unspecified vulnerability in the Oracle Portal component in Oracle Fusion Middleware 11.1.1.6.0 allows remote authenticated users to affect confidentiality and integrity via unknown vectors related to Demos.
- Record
CVE-2013-3831- Updated
- 2026-11-02
EUVDEUVD-2013-3763 No score
Unspecified vulnerability in the Oracle Portal component in Oracle Fusion Middleware 11.1.1.6.0 allows remote authenticated users to affect confidentiality and integrity via unknown vectors related to Demos.
- Record
EUVD-2013-3763- Updated
- 2026-11-03
GitHub AdvisoriesGHSA-cx2c-rv4q-2mhx No score
Unspecified vulnerability in the Oracle Portal component in Oracle Fusion Middleware 11.1.1.6.0...
Unspecified vulnerability in the Oracle Portal component in Oracle Fusion Middleware 11.1.1.6.0 allows remote authenticated users to affect confidentiality and integrity via unknown vectors related to Demos.
- Record
GHSA-cx2c-rv4q-2mhx- Updated
- 2026-11-02
Affected products
History
| Recorded | Changed | Sources |
|---|---|---|
| aliases | EUVD | |
| first indexed | CVE List, GitHub Advisories, NVD |
Dates are when Every CVE recorded each change. Upstream dates may differ.
In short
CVE-2013-3831 is a medium vulnerability (CVSS 5.5) in Oracle Fusion Middleware, published October 16, 2013. No source lists public exploit code. EPSS puts the chance of exploitation in the next 30 days at 0.95%, the 61st percentile. No source names a fixed version.